Osprey Medical
  • DyeVert™
    • DyeVert™ PLUS EZ
    • Instructions for Use – United States Only
  • Be Kind to Kidneys™
  • Patients
    • About Your Kidneys
    • Patients at Risk
    • Kidney Kindness in the Cath Lab
    • Martha’s Story
    • DyeVert™ Plus System
  • International
    • DyeVert™ PLUS EZ
    • DyeVert™ Power XT
    • Instructions for Use – International
    • Instructions for Use – Australia
    • Instructions for Use – Canada
  • About Us
    • Management
    • Board of Directors
    • News
    • Patents
  • Investors
    • Financial Information
    • Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Contact Us
  • Search
  • Menu Menu
News
DyeVert™ PLUS System

Osprey Introduces DyeVert PLUS at TCT

November 2, 2016/in News

Osprey Medical is pleased to announce the expansion of its portfolio with introduction of the DyeVert™ PLUS Contrast Modulation/Monitoring System. This new platform integrates the current DyeVert technology with substantial patient management and monitoring capabilities. The system has received European CE Mark and FDA clearance is pending. The Company anticipates US availability Q1 2017.

Highlighted at the Transcatheter Cardiovascular Therapeutics (“TCT”) Conference, held October 29 – November 2 in Washington DC, the DyeVert PLUS received publicity via both podium presence and considerable booth exposure. As one of the world’s largest gatherings of heart specialists, TCT hosts over 6,000 medical professionals in the fields of interventional cardiology and vascular medicine.

Read more

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg 733 813 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2016-11-02 01:17:002017-05-06 19:02:12Osprey Introduces DyeVert PLUS at TCT

Osprey Medical Events

NCDR 2019 Annual Conference
March 13-15, 2019
New Orleans, LA

ACC.19
March 16-18, 2019
New Orleans, LA

SCAI Conference
May 19-22, 2019
Las Vegas, NV

TCT 2019
September 25-29, 2019
San Francisco, CA

Recent Posts

  • Osprey receives Supplier Horizon Award from Premier Inc
  • GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
  • US Government to Transform Kidney Care
  • AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference
  • Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System

Archives

  • September 2020
  • July 2020
  • July 2019
  • June 2019
  • December 2018
  • September 2018
  • June 2017
  • March 2017
  • November 2016
  • October 2016
  • May 2016

© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.

Osprey YouTubeOsprey TwitterOsprey Facebook

Contact     Resources     Privacy     Terms of Use

Contact     Resources     Privacy     Terms of Use

Osprey to present at TCT 2016 DyeVert™ PLUS System DyeVert™ PLUS System Osprey Medical Receives US FDA Clearance for DyeVert™ Plus
Scroll to top

Analyst Coverage Disclaimer Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.

Check if you have read and acknowledged.